LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 21 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,574 | -18.6% | 12,873 | +7.4% | 0.00% | – |
| Q2 2023 | $87,962 | +244238.9% | 11,984 | +108845.5% | 0.00% | – |
| Q4 2022 | $36 | -99.8% | 11 | -99.8% | 0.00% | – |
| Q3 2022 | $21,000 | -51.2% | 5,739 | -58.5% | 0.00% | – |
| Q2 2022 | $43,000 | -68.1% | 13,823 | -45.5% | 0.00% | – |
| Q1 2022 | $135,000 | +17.4% | 25,367 | +7.8% | 0.00% | – |
| Q4 2021 | $115,000 | -19.0% | 23,525 | +46.4% | 0.00% | – |
| Q3 2021 | $142,000 | +1928.6% | 16,072 | +3878.2% | 0.00% | – |
| Q1 2021 | $7,000 | – | 404 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,273,221 | $12,139,000 | 0.93% |
| Integral Health Asset Management, LLC | 47,600 | $254,000 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $4,328,000 | 0.02% |
| Orbimed Advisors | 113,500 | $606,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $363,000 | 0.01% |
| BAILARD, INC. | 21,200 | $110,000 | 0.00% |
| Alyeska Investment Group, L.P. | 62,500 | $334,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,045,929 | $5,428,000 | 0.00% |
| Veritable, L.P. | 20,534 | $110,000 | 0.00% |
| Laurion Capital Management LP | 20,918 | $109,000 | 0.00% |